抗肿瘤治疗相关心功能不全的预防和治疗策略进展  

Advances in prevention and treatment strategies for cancer therapy-related cardiac dysfunction

作　　者：张新鑫 张艳丽[1] 方凤奇[2] 刘基巍[2] 夏云龙[1] 刘莹[1] Zhang Xinxin;Zhang Yanli;Fang Fengqi;Liu Jiwei;Xia Yunlong;Liu Ying(Department of Cardiology,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China;Department of Oncology,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China)

机构地区：[1]大连医科大学附属第一医院心内科,116011 [2]大连医科大学附属第一医院肿瘤科,116011

出　　处：《中国心血管杂志》2023年第6期595-600,共6页Chinese Journal of Cardiovascular Medicine

基　　金：国家自然科学基金(82170385)。

摘　　要：随着医疗技术的不断发展,传统、靶向及免疫抗肿瘤治疗有效提升了肿瘤患者的生存率,而癌症幸存者的长期生存使抗肿瘤治疗相关心血管毒性日益凸显。通过影像学及生物标志物监测,早期识别及治疗心血管疾病高风险患者,是肿瘤心脏病学专家关注的焦点。With the continuous development of medical technology,conventional,targeted and immune cancer therapy has effectively improved the survival rate of tumor patients,and the long-term survival of cancer survivors has brought cancer therapy-related cardiovascular toxicity increasingly prominent.Early identification and treatment of patients at high risk of cardiovascular disease through imaging and biomarker monitoring is the focus of cardio-oncologists.

关 键 词：肿瘤心脏病学 心血管毒性 心功能不全 预防 治疗 

分 类 号：R730.5[医药卫生—肿瘤] R541[医药卫生—临床医学]